Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV randomized open-label study of long-term treatment strategies for GERD-related symptoms in primary care
2006-001316-76Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole and Almasilate in gastroesophageal reflux disease (GERD) (3 arms), sponsored by AstraZeneca. Primary endpoint: Number of treatment failures during the maintenance phase. Started May 2006; status: completed.
02
Drugs
esomeprazoleAlmasilate
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-001316-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001316-76.